SHIP1 suppresses tumour growth in hematopoietic cancers via its negative regulation of PI3K/AKT signalling by hydrolysis of PtdIns(3,4,5)P3 to PtdIns(3,4)P2 [113,114]. Here, INPP5D is linked to hematopoietic and lymphoid cell neoplasm.